OCGN - Ocugen, Inc. News

Ocugen To Enter License Agreement With Roots Pharmaceutical For Rights To OCU400, Its Novel Modifier

Cumulative sales milestones up to $255 million and modest upfront/near-term development milestonesRo

Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene

Cumulative sales milestones up to $255 million and modest upfront/near-term development milestones R

marketbeat.com

Ocugen Eyes 3 Retinal Gene Therapy Filings as Late-Stage Pipeline Advances

Ocugen NASDAQ: OCGN outlined plans to advance three late-stage retinal disease programs, with compan

Ocugen to Participate in Upcoming July Industry Conferences

MALVERN, Pa. , July 01, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN)

Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?

Ocugen (OCGN) reported earnings 30 days ago. What's next for the stock?

Ocugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Care

OCGN is advancing gene-agnostic eye therapies across retinal diseases, with key trial data and regul

Is OCGN Stock Worth the Risk Ahead of 2026-27 Eye Gene Therapy Data?

Ocugen faces cash burn and dilution risks, but upcoming eye gene therapy data and planned filings th

OCGN's Catalyst Calendar for Trial Data and Filings Through 2028

Ocugen's three ocular gene therapy programs could deliver trial data, filings, and potential BLA mil

Ocugen to Participate in Upcoming June Investor and Industry Conferences

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN),

Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11

Canaccord Genuity analyst Whitney Ijem maintains Ocugen (NASDAQ:OCGN) with a Buy and lowers the p

Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes

MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN),

fool.com

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking th

Ocugen to Participate in Upcoming May Scientific and Investor Conferences

MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN),

Ocugen (OCGN) Upgraded to Buy: Here's Why

Ocugen (OCGN) might move higher on growing optimism about its earnings prospects, which is reflected

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

Ocugen swings to a wider Q1 loss as costs climb, but pipeline milestones and gene therapy data keep

seekingalpha.com

Ocugen, Inc. (OCGN) Q1 2026 Earnings Call Transcript

12 Health Care Stocks Moving In Tuesday's Intraday Session

Full Transcript: Ocugen Q1 2026 Earnings Call

Ocugen (OCGN) Reports Q1 Loss, Beats Revenue Estimates

Ocugen (OCGN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate

Ocugen Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $1.533M Beat $540.000K Estimate

Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which missed the analyst consens

Ocugen Provides Business Update with First Quarter 2026 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET Positive 12-month data from the OCU410 Phase 2 ArM

Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes

MALVERN, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) today announce

GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market S

Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance

Earnings Scheduled For May 5, 2026

12 Health Care Stocks Moving In Monday's After-Market Session

Ocugen Plans To Commence $115M Senior Notes Offering

Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a pioneering biotechnology l

Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCG

Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and Fir

MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN)

HC Wainwright & Co. Maintains Buy on Ocugen, Raises Price Target to $10

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ocugen (NASDAQ:OCGN) with a Buy

Ocugen Eye Disease Gene Therapy Data Trails Earlier Results, Stocks Falls

Ocugen stock falls after Phase 2 OCU410 data for dry AMD trails interim results, despite lesion redu

Ocugen's 12-month Data From Phase 2 ArMaDa trial of OCU410 (AAV5-RORA) For Geographic Atrophy Second

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth

Canaccord Genuity Initiates Coverage On Ocugen with Buy Rating, Announces Price Target of $12

Canaccord Genuity analyst Whitney Ijem initiates coverage on Ocugen (NASDAQ:OCGN) with a Buy rati

Why Is Ocugen Stock Soaring Today?

Ocugen shares are surging Wednesday afternoon after Oppenheimer analyst Leland Gershell initiated co

12 Health Care Stocks Moving In Wednesday's Intraday Session

Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving High

Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations Fo

Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst r

Oppenheimer Initiates Coverage On Ocugen with Outperform Rating, Announces Price Target of $10

Oppenheimer analyst Leland Gershell initiates coverage on Ocugen (NASDAQ:OCGN) with a Outperform

Earnings Scheduled For March 4, 2026

Earnings Scheduled For November 5, 2025

Earnings Scheduled For August 1, 2025

Earnings Scheduled For March 5, 2025

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 838 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

During Thursday, 849 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday

Tuesday's session saw 729 companies set new 52-week lows.

40 Stocks Moving in Thursday's Pre-Market Session

Gainers AmeriServ Financial, Inc. (NASDAQ: ASRV) rose 199.3% to $12.30 in pre-market trading.